Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining Drug Registration Certificate by Wholly-owned Subsidiary
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-obtaining-drug-registration-certificate-by-wholly-owned-subsidiary
Release
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Wholly-owned Sub-subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on Proposed Selection of Partial Drugs for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
- Announcement on Wholly-owned Subsidiary's Passing GMP Compliance Inspection for Drugs
- Announcement on Provision for Impairment
- Announcement on Resolutions of the 1st Meeting of the 9th Board of Directors
Later from Shanghai Shyndec Pharmaceutical
- by Holding Subsidiary
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on Voluntary Information Disclosure of Wholly-owned Subsidiary's Drug Passing Consistency Evaluation for Generic Drugs
- Earnings Preannouncement for Q1 2026
- Announcement on Progress in Providing Guarantees for Subsidiaries
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical